Kazia Therapeutics stock soared after positive clinical trials, which raises its profile amongst pharmas looking to buy promising candidates. More
Articles
The Top 3 Healthcare Stocks to Buy Now: Summer 2024
Investors should consider the long term prospects of the following three healthcare stocks as the U.S. population ages. More
What Are the Hottest EV Stocks Right Now? 3 Top Picks.
These are the EV stocks to buy as they represent companies with strong fundamentals and an innovation edge in the industry. More
HSBC Stock Earnings: HSBC Holdings Reported Results for Q2 2024
HSBC Holdings just reported results for the second quarter of 2024. More
FVRR Stock Earnings: Fiverr International Beats EPS, Misses Revenue for Q2 2024
FVRR stock results show that Fiverr International beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. More
TAK Stock Earnings: Takeda Pharmaceutical Reported Results for Q1 2024
Takeda Pharmaceutical just reported results for the first quarter of 2024. More
7 Cheap Stocks Under $10 With 10X Potential: July 2024
These seven cheap stocks under $10 have the potential to deliver massive returns if the stars align for them. More
